TMPRSS2 and uterine corpus endometrial carcinoma: However, elevated expression of TMPRSS2 was reported in bladder urothelial carcinoma (BLCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), cholangiocarcinoma (CHOL), glioblastoma multiforme (GBM), kidney chromophobe (KICH), pancreatic adenocarcinoma (PAAD), prostate adenocarcinoma (PRAD) and uterine corpus endometrial carcinoma (UCEC; Figure 1B,C, Figure S1).